Historique
Bulletin de Périodique
Addiction , Vol.110, n°6 - June 2015
Paru le :
01/06/2015
Article en page(s) :
889-1055
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Why are we not doing more for alcohol use disorder among conflict-affected populations? [Editorial]. Roberts B., Ezard N., p. 889-890.
- The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence [For debate]. Davoli M., Amato L., Clark N., Farrell M., Hickman M., Hill S., et al., p. 891-898.
- Do Cochrane systematic reviews meet WHO needs? Barbui C., p. 899-900.
- Time, consensus and implementation: challenges for effective knowledge exchange. Ferri M., Dias S., p. 900-901.
- Response to commentaries. Davoli M., Amato L., Tovey D., p. 902-903.
- Global statistics on addictive behaviours: 2014 status report. Gowing L.R., Ali R.L., Allsop S., Marsden J., Turf E.E., West R., et al., p. 904-919.
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Donoghue K., Elzerbi C., Saunders R., Whittington C., Pilling S., Drummond C., p. 920-930.
- The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Wakefield J.C., Schmitz M.F., p. 931-942.
- Commentary on Wakefield & Schmitz (2015): Diagnosing an alcohol use disorder-what criteria should be used? Najman J.M., p. 943-944.
- Heterogeneous dose-response and college student drinking: examining problem risks related to low drinking levels. Gruenewald P.J., Mair C., p. 945-954.
- The impact of extended closing times of alcohol outlets on alcohol-related injuries in the nightlife areas of Amsterdam: a controlled before-and-after evaluation. de Goeij M.C.M., Veldhuizen E.M., Buster M.C.A., Kunst A.E., p. 955-964.
- Commentary on de Goeij et al. (2015): Evidence of harm from late night alcohol sales continues to strengthen. Kypri K., p. 965-966.
- Is there a link between per capita alcohol consumption and youth drinking? A time-series analysis for Sweden in 1972-2012. Norström T., Raninen J., p. 967-974.
- Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first? de Vos A.S., Prins M., Kretzschmar M.E.E., p. 975-983.
- Commentary on de Vos et al. (2015): The changing landscape of hepatitis C treatment - not 'can we cure?' but 'who should we cure first?' Is this an ethical approach? Hellard M., Scott N., p. 984-985.
- Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study. Teesson M., Marel C., Darke S., Ross J., Slade T., Burns L., et al., p. 986-993.
- Commentary on Teesson et al. (2015): The Australian Treatment Outcome Study - implications for treatment philosophies, policy, political processes and practice. Comiskey C.M., p. 994-995.
- Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Evans E., Li L., Min J., Huang D., Urada D., Liu L., et al., p. 996-1005.
- Commentary on Evans et al. (2015): Coherent long-term treatment approaches-superior in the treatment of opioid dependence. Clausen T., p. 1006-1007.
- Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial. Lee J.D., McDonald R., Grossman E., McNeely J., Laska E., Rotrosen J., et al., p. 1008-1014.
- Examining the association between substance use disorder treatment and smoking cessation. Shu C., Cook B.L., p. 1015-1024.
- Commentary on Shu & Cook (2015): The facts are clear. Schroeder S., Guydish J., p. 1025-1026.
- An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Gray K.M., McClure E.A., Baker N.L., Hartwell K.J., Carpenter M.J., Saladin M.E., p. 1027-1034.
- Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. Fatseas M., Serre F., Alexandre J.-M., Debrabant R., Auriacombe M., Swendsen J., p. 1035-1042.
- Commentary on Fatseas et al. (2015): Ecological momentary assessment - new insights and opportunities. Field M., p. 1043-1044.
- Why are we not doing more for alcohol use disorder among conflict-affected populations? [Editorial]. Roberts B., Ezard N., p. 889-890.
- The role of Cochrane reviews in informing international guidelines: a case study of using the Grading of Recommendations, Assessment, Development and Evaluation system to develop World Health Organization guidelines for the psychosocially assisted pharmacological treatment of opioid dependence [For debate]. Davoli M., Amato L., Clark N., Farrell M., Hickman M., Hill S., et al., p. 891-898.
- Do Cochrane systematic reviews meet WHO needs? Barbui C., p. 899-900.
- Time, consensus and implementation: challenges for effective knowledge exchange. Ferri M., Dias S., p. 900-901.
- Response to commentaries. Davoli M., Amato L., Tovey D., p. 902-903.
- Global statistics on addictive behaviours: 2014 status report. Gowing L.R., Ali R.L., Allsop S., Marsden J., Turf E.E., West R., et al., p. 904-919.
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Donoghue K., Elzerbi C., Saunders R., Whittington C., Pilling S., Drummond C., p. 920-930.
- The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates. Wakefield J.C., Schmitz M.F., p. 931-942.
- Commentary on Wakefield & Schmitz (2015): Diagnosing an alcohol use disorder-what criteria should be used? Najman J.M., p. 943-944.
- Heterogeneous dose-response and college student drinking: examining problem risks related to low drinking levels. Gruenewald P.J., Mair C., p. 945-954.
- The impact of extended closing times of alcohol outlets on alcohol-related injuries in the nightlife areas of Amsterdam: a controlled before-and-after evaluation. de Goeij M.C.M., Veldhuizen E.M., Buster M.C.A., Kunst A.E., p. 955-964.
- Commentary on de Goeij et al. (2015): Evidence of harm from late night alcohol sales continues to strengthen. Kypri K., p. 965-966.
- Is there a link between per capita alcohol consumption and youth drinking? A time-series analysis for Sweden in 1972-2012. Norström T., Raninen J., p. 967-974.
- Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first? de Vos A.S., Prins M., Kretzschmar M.E.E., p. 975-983.
- Commentary on de Vos et al. (2015): The changing landscape of hepatitis C treatment - not 'can we cure?' but 'who should we cure first?' Is this an ethical approach? Hellard M., Scott N., p. 984-985.
- Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian Treatment Outcome Study. Teesson M., Marel C., Darke S., Ross J., Slade T., Burns L., et al., p. 986-993.
- Commentary on Teesson et al. (2015): The Australian Treatment Outcome Study - implications for treatment philosophies, policy, political processes and practice. Comiskey C.M., p. 994-995.
- Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Evans E., Li L., Min J., Huang D., Urada D., Liu L., et al., p. 996-1005.
- Commentary on Evans et al. (2015): Coherent long-term treatment approaches-superior in the treatment of opioid dependence. Clausen T., p. 1006-1007.
- Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial. Lee J.D., McDonald R., Grossman E., McNeely J., Laska E., Rotrosen J., et al., p. 1008-1014.
- Examining the association between substance use disorder treatment and smoking cessation. Shu C., Cook B.L., p. 1015-1024.
- Commentary on Shu & Cook (2015): The facts are clear. Schroeder S., Guydish J., p. 1025-1026.
- An exploratory short-term double-blind randomized trial of varenicline versus nicotine patch for smoking cessation in women. Gray K.M., McClure E.A., Baker N.L., Hartwell K.J., Carpenter M.J., Saladin M.E., p. 1027-1034.
- Craving and substance use among patients with alcohol, tobacco, cannabis or heroin addiction: a comparison of substance- and person-specific cues. Fatseas M., Serre F., Alexandre J.-M., Debrabant R., Auriacombe M., Swendsen J., p. 1035-1042.
- Commentary on Fatseas et al. (2015): Ecological momentary assessment - new insights and opportunities. Field M., p. 1043-1044.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
L. R. GOWING ;
R. L. ALI ;
S. ALLSOP ;
J. MARSDEN ;
E. E. TURF ;
R. WEST ;
J. WITTON
|
2015
Dans Addiction (Vol.110, n°6, June 2015) Article : Périodique
Dans Addiction (Vol.110, n°6, June 2015) Article : Périodique
Background and aims: Addictive behaviours are among the greatest scourges on humankind. It is important to estimate the extent of the problem globally and in different geographical regions. Such estimates are available, but there is a need to co[...]
J. C. WAKEFIELD ;
M. F. SCHMITZ
|
2015
Dans Addiction (Vol.110, n°6, June 2015) Article : Périodique
Dans Addiction (Vol.110, n°6, June 2015) Article : Périodique
Aims: To formulate harmful dysfunction (HD) diagnostic criteria for alcohol use disorder (AUD) and test whether they increase validity relative to standard DSM criteria, as evidenced by lowered prevalence, increased validator levels including se[...]
Aims: To estimate the relationship between per capita alcohol consumption and youth drinking in Sweden during the last 40 years and to estimate the relationship between female and male youth drinking during the 40-year study period.
Design, set[...]